News Topical, Digital Desk : The country's leading brokerages have released new reports on several key stocks. These reports focus on the healthcare, pharma, airport, energy, and consumer sectors. They recommend buying stocks in several sectors. The report expresses confidence in companies like Fortis Healthcare, Lupin, GMR Airports, Oil and Natural Gas Corporation (ONGC), and Marico, while Vedant Fashions has been downgraded.
BUY advice on these stocks?
- Fortis Healthcare: Strong profit growth
has prompted Citi to recommend a buy rating on Fortis Healthcare with a target price of ₹1,120. The company's revenue grew 19% and EBITDA grew 29%. Both the hospital and diagnostics businesses performed well. - Lupin: Three brokerages,
Citi and Jefferies, have set a target price of ₹2,540 on Lupin. EBITDA has increased by 62%. Morgan Stanley also notes strength in the company's US business. - GMR Airports: Returning from Losses to Profit
Jefferies and Citi have recommended a Buy on GMR Airports. The company's EBITDA increased 73% to ₹1,710 crore. The company returned to profitability due to increased air traffic and non-aero revenue. - ONGC: Expectations of production growth
CLSA and Jefferies have set a target price of ₹315–₹325 on ONGC. The company's gas production is expected to increase by more than 15% by FY27. Additionally, the nearly 50% dividend payout is attractive to investors. - Indus Towers : BUY, target ₹540. Despite a 40% rise in the last 6 months, it still has potential ahead.
- Coal India : BUY, Target ₹450, 7% dividend very good.
- Siemens Energy : BUY, target ₹3,700, strong growth in the coming years.
- Torrent Pharma : BUY, Target ₹4,690.
What's at risk?
Morgan Stanley has given Vedant Fashions an "underweight" rating and lowered its target price to ₹400. According to the brokerage, the company may face competition and business pressure.
RBI's draft regulations could impact the trading business. According to brokerage Citi, the RBI's new draft regulations could impact the trading business. This could affect brokers, clearing members, and exchanges. There's a possibility of reduced trading in some segments. However, it's too early to say how much this will impact profits.
Advice for investors: Brokerage reports clearly indicate good opportunities in the healthcare, pharmaceutical, and energy sectors. However, be cautious with stocks like Vedant Fashions. Before investing, do your own research and understand the risks.
--Advertisement--
Share



